Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities

- Sun, Claire Xin, Daniel, Paul, Adjumain, Shazia, Sun, Christie, Chong, Wai Chin, Fernando, Dasun, Drinkwater, Caroline, Tourchi, Motahhareh, Habarakada, Dilru, Sooraj, Dhanya, Carvalho, Diana, Storm, Phillip B., Bradshaw, Gabrielle, Baubet, Valerie, Sayles, LC, Fernandez, E, Nguyen, T, Pörksen, M, Doan, A, Crombie, DE, Panday, M, Zhukova, N, Dun, Matthew D., Shi, Hui, Ludlow, LE, Day, B, Stringer, BW, Neeman, N, Rubens, JA, Raabe, EH, Vinci, M, Tyrrell, V, Fletcher, JI, Ekert, PG, Loi, Melissa, Dumevska, B, Ziegler, DS, Tsoli, M, Syed Sulaiman, NF, Loh, AHP, Low, SYY, Sweet-Cordero, EA, Monje, M, Resnick, A, Jones, C, Chew, Nicole, Downie, P, Williams, B, Rosenbluh, J, Gough, D, Cain, JE, Firestein, R, Parackal, Sarah, Tsui, Vanessa, Liang, Yuqing, Koptyra, Mateusz

ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma

- Jackson, Evangeline R., Duchatel, Ryan J., Le Grand, Marion, Kearney, Padraic S., Douglas, Alicia M., Findlay, Izac J., Germon, Zacary P., McEwen, Holly P., Beitaki, Tyrone S., Patabendige, Adjanie, Skerrett-Byrne, David A., Nixon, Brett, Staudt, Dilana E., Smith, Nathan D., Day, B, Manoharan, N, Nagabushan, S, Hansford, JR, Govender, D, McCowage, GB, Firestein, R, Howlett, M, Endersby, R, Persson, Mika L., Gottardo, NG, Alvaro, F, Waszak, SM, Larsen, MR, Colino-Sanguino, Y, Valdés-Mora, F, Rakotomalala, A, Meignan, S, Pasquier, E, Andre, N, Mannan, Abdul, Hulleman, E, Eisenstat, DD, Vitanza, NA, Nazarian, J, Koschmann, C, Mueller, S, Cain, JE, Dun, MD, Yadavilli, Sridevi, Parackal, Sarah, Game, Shaye, Chong, Wai Chin, Jayasekara, W. Samantha N.